The European Medicines Agency (EMEA) is recommending that six new medicines be approved for sale in Europe and that two others be given broader indications. This follows an analysis of the product data by the agency’s Committee for Medicinal Products for Human Use at a meeting from 15 to 18 December 2008. The European Commission will formally issue the marketing authorisations.
